Cargando…
Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis
BACKGROUND: Sirolimus has been confirmed to be effective for lymphangioleiomyomatosis (LAM), a rare multisystem neoplastic disease in women. The long-term effects of sirolimus treatment for LAM, however, are largely unknown. We aimed to analyze the long-term efficacy and safety of sirolimus therapy...
Autores principales: | Hu, Siqi, Wu, Xiuxiu, Xu, Wenshuai, Tian, Xinlun, Yang, Yanli, Wang, Shao-Ting, Liu, Song, Xu, Xingxiang, Xu, Kai-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702727/ https://www.ncbi.nlm.nih.gov/pubmed/31429781 http://dx.doi.org/10.1186/s13023-019-1178-2 |
Ejemplares similares
-
Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study
por: Zhan, Yongzhong, et al.
Publicado: (2018) -
Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study
por: Cheng, Chongsheng, et al.
Publicado: (2022) -
The value of transbronchial lung biopsy in the diagnosis of lymphangioleiomyomatosis
por: Xu, Wenshuai, et al.
Publicado: (2021) -
Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018) -
Recent advances in the management of lymphangioleiomyomatosis
por: Xu, Kai-Feng, et al.
Publicado: (2018)